NanOZ LNP-siRNA(GAPDH)
siRNA targeting GAPDH formulated in Lipid NanoParticle.
Lipid Nanoparticles (LNPs) represent the most effective and safe delivery systems for the translational success of nucleic acid drugs.
NanOZ LNP-siRNA is designed to not only protect siRNA from degradation but also facilitate intracellular uptake and thus potentiate its efficacy.
Our delivery systems are produced through microfluidic technology resulting in monodisperse NanOZ LNP-siRNA with narrow size distribution and high encapsulation efficiency (>80%). OZ Biosciences developed optimized NanOZ LNP-siRNA(GAPDH) to improve stability and performance.
Concentration: 400 nM siRNA in LNPs
Kit contents:
- LNP10250SIRNA2: 0.25 mL (5*50 µL) of LNP-siRNA GAPDH.
- LNP10500SIRNA2: 0.5 mL (10*50 µL) of LNP-siRNA GAPDH.
- LNP11000SIRNA2: 1 mL (20*50 µL) of LNP-siRNA GAPDH.
Storage: NanOZ LNP-siRNA must be stored at -80°C for long-term storage (6 months). We recommend to minimize freeze-thaw cycles to preserve LNPs integrity.
Shipping Conditions: Dry Ice. (Dry ice fee included in shipping cost.)
This product is manufactured "on demand", which means that no stock is produced, so the expected delivery time is 2 to 3 weeks.
| Catalog number | Unit Size | Price excl tax | Quantity / Buy |
| LNP10250SIRNA2 |
0.25 mL (5*50 µL) of LNP-siRNA GAPDH
|
$500.00
|
|
| LNP10500SIRNA2 |
0.5 mL (10*50 µL) of LNP-siRNA GAPDH
|
$900.00
|
|
| LNP11000SIRNA2 |
1 mL (20*50 µL) of LNP-siRNA GAPDH
|
$1,500.00
|
|
Citation database
Related products
NanOZ LNP-siRNA(GFP)
NanOZ LNP-siRNA
siRNA targeting GFP formulated in Lipid Nanoparticle
NanOZ LNP-siRNA(NT Cy5)
NanOZ LNP-siRNA
Cy5-labeled scrambled siRNA formulated in Lipid Nanoparticle
LNP D-Lin-MC3-DMA
NanOZ LNP-siRNA
Lipid Nanoparticles with D-Lin-MC3-DMA ionizable lipid available with...